Table of Contents
| << Previous Issue | Apr 2011 (Vol: 2011, Issue: 4) | Next Issue >> |
- Section: Joint Venture
-
Teva and Procter & Gamble Form Joint Venture to Accelerate OTC Drug Sales
-
Merck & Co. Enhances its Emerging Markets Presence with Joint Venture with Sun Pharma
- Section: Licensing
-
Human Genome Sciences Licenses FivePrime Therapeutics’ Lead Cancer Drug
- Section: Mergers & Acquisitions
-
Quest Diagnostics Aims to Bolster its Genetic Testing Platform with Celera Acquisition
-
Cephalon Agrees to Buy Gemin X Pharmaceuticals for up to US$525 M
-
Merck & Co. Bolsters its Eye Care Franchise with Inspire Pharmaceuticals Acquisition
-
RXi Pharmaceuticals Looks Beyond RNAi Therapeutics with Apthera Acquisition
-
Endo to Acquire American Medical Systems and Advance its Diversification
-
SciClone Strengthens its Presence in China with NovaMed Acquisition
- Section: Research & Development
-
Abbott Becomes Seattle Genetics’ Latest Antibody-Drug Conjugate Collaborator
-
Gilead Sciences and Yale School of Medicine in Potential US$100 M Cancer Research Pact
-
Pfizer Continues its Pursuit of Rare Disease Therapies with Zacharon Collaboration
-
Medtronic and Eli Lilly in Drug-Device Pact for Parkinson’s Disease
RSS